{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T22:21:06Z","timestamp":1757456466394},"reference-count":51,"publisher":"Spandidos Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Clin Oncol"],"DOI":"10.3892\/mco.2022.2500","type":"journal-article","created":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T16:13:17Z","timestamp":1644423197000},"source":"Crossref","is-referenced-by-count":2,"title":["Patient with prostatic adenocarcinoma with plasmacytoid features and an aberrant immunohistochemical phenotype diagnosed by biopsy and a mini\u2011review of plasmacytoid features in the genitourinary system: A case report"],"prefix":"10.3892","volume":"16","author":[{"given":"Konstantina","family":"Zacharouli","sequence":"first","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Biopolis, 41500 Larissa, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitra","family":"Vageli","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Biopolis, 41500 Larissa, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Koukoulis","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Biopolis, 41500 Larissa, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Ioannou","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, School of Health Sciences, University of Thessaly, Biopolis, 41500 Larissa, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2022,1,20]]},"reference":[{"key":"key20220302120108_b1-MCO-16-3-02500","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"key20220302120108_b2-MCO-16-3-02500","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/mnfr.200700511","article-title":"International epidemiology of prostate cancer: Geographical distribution and secular trends","volume":"53","author":"Baade","year":"2009","journal-title":"Mol Nutr Food Res"},{"issue":"a030411","key":"key20220302120108_b3-MCO-16-3-02500","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a030411","article-title":"Histopathology of prostate cancer","volume":"7","author":"Humphrey","year":"2017","journal-title":"Cold Spring Harb Perspect Med"},{"key":"key20220302120108_b4-MCO-16-3-02500","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1111\/his.13767","article-title":"Grading of prostate cancer: A work in progress","volume":"74","author":"Kweldam","year":"2019","journal-title":"Histopathology"},{"key":"key20220302120108_b5-MCO-16-3-02500","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/j.humpath.2009.01.001","article-title":"Plasmacytoid urothelial carcinoma of the bladder","volume":"40","author":"Lopez-Beltran","year":"2009","journal-title":"Hum Pathol"},{"key":"key20220302120108_b6-MCO-16-3-02500","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1093\/ajcp\/aqx029","article-title":"Plasmacytoid urothelial carcinoma of the urinary bladder: A clinicopathologic and immunohistochemical analysis of 49 cases","volume":"147","author":"Fox","year":"2017","journal-title":"Am J Clin Pathol"},{"key":"key20220302120108_b7-MCO-16-3-02500","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.urology.2016.09.053","article-title":"Outcomes following radical cystectomy for plasmacytoid urothelial carcinoma: Defining the need for improved local cancer control","volume":"102","author":"Cockerill","year":"2017","journal-title":"Urology"},{"key":"key20220302120108_b8-MCO-16-3-02500","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.humpath.2019.10.010","article-title":"Plasmacytoid acinar adenocarcinoma of the prostate: A newly described variant of prostate cancer","volume":"94","author":"Al-Hussain","year":"2019","journal-title":"Hum Pathol"},{"key":"key20220302120108_b9-MCO-16-3-02500","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1097\/PAS.0000000000001550","article-title":"Clinicopathological study of Gleason pattern 5 prostatic adenocarcinoma with \u2018single-cell\u2019 growth reveal 2 distinct types, one with \u2018plasmacytoid \u2018features","volume":"44","author":"Nguyen","year":"2020","journal-title":"Am J Pathol"},{"key":"key20220302120108_b10-MCO-16-3-02500","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.euf.2017.06.013","article-title":"The impact of plasmacytoid variant histology on the survival of patients with urothelial carcinoma of bladder after radical cystectomy","volume":"5","author":"Li","year":"2019","journal-title":"Eur Urol Focus"},{"key":"key20220302120108_b11-MCO-16-3-02500","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1016\/j.juro.2012.11.084","article-title":"Plasmacytoid urothelial carcinoma, a chemosensitive cancer with poor prognosis, and peritoneal carcinomatosis","volume":"189","author":"Dayyani","year":"2013","journal-title":"J Urol"},{"issue":"483","key":"key20220302120108_b12-MCO-16-3-02500","article-title":"Plasmacytoid variant urothelial carcinoma: Clinicopathologic outcomes and experience with neoadjuvant chemotherapy","volume":"37","author":"Ericson","year":"2019","journal-title":"J Clin Oncol"},{"key":"key20220302120108_b13-MCO-16-3-02500","doi-asserted-by":"crossref","first-page":"e16007","DOI":"10.1200\/JCO.2019.37.15_suppl.e16007","article-title":"Patient (pt) characteristics, treatment patterns, outcomes and prognostic factors in plasmacytoid urothelial carcinoma (PUC)","volume":"37 (Suppl 15)","author":"Diamantopoulos","year":"2019","journal-title":"J Clin Oncol"},{"key":"key20220302120108_b14-MCO-16-3-02500","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/dc.24331","article-title":"Cytological features of micropapillary and plasmacytoid variants of urothelial carcinoma","volume":"48","author":"Straccia","year":"2020","journal-title":"Diagn Cytopathol"},{"key":"key20220302120108_b15-MCO-16-3-02500","doi-asserted-by":"publisher","first-page":"158","DOI":"10.12659\/ajcr.906679","article-title":"Plasmacytoid urothelial carcinoma of ureter with retroperitoneal metastasis: A case report","volume":"19","author":"Jibril","year":"2018","journal-title":"Am J Case Rep"},{"issue":"124","key":"key20220302120108_b16-MCO-16-3-02500","doi-asserted-by":"publisher","DOI":"10.1186\/s13000-020-01043-6","article-title":"Plasmacytoid urothelial carcinoma of renal pelvis with positive zinc finger E-box-binding homeobox 1: A case report","volume":"15","author":"Takada-Owada","year":"2020","journal-title":"Diagn Pathol"},{"key":"key20220302120108_b17-MCO-16-3-02500","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1245\/s10434-012-2709-4","article-title":"Nuclear E-cadherin expression is associated with the loss of membranous E-cadherin, plasmacytoid differentiation and reduced overall survival in urothelial carcinoma of the bladder","volume":"20","author":"Keck","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"key20220302120108_b18-MCO-16-3-02500","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1038\/modpathol.2010.187","article-title":"E-cadherin expression in plasmacytoid, signet ring cell and micropapillary variants of urothelial carcinoma: Comparison with usual-type high-grade urothelial carcinoma","volume":"24","author":"Lim","year":"2011","journal-title":"Mod Pathol"},{"issue":"164","key":"key20220302120108_b19-MCO-16-3-02500","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-019-0489-1","article-title":"Expression of E-cadherin and specific CXCR3 isoforms impact each other in prostate cancer","volume":"17","author":"Ma","year":"2019","journal-title":"Cell Commun Signal"},{"key":"key20220302120108_b20-MCO-16-3-02500","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.humpath.2020.07.006","article-title":"Invasive plasmacytoid urothelial carcinoma: A comparative study of E-cadherin and P120 catenin","volume":"102","author":"Sangoi","year":"2020","journal-title":"Hum Pathol"},{"key":"key20220302120108_b21-MCO-16-3-02500","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.humpath.2018.10.033","article-title":"Targeted sequencing of plasmacytoid urothelial carcinoma reveals frequent TERT promoter mutations","volume":"85","author":"Palsgrove","year":"2019","journal-title":"Hum Pathol"},{"key":"key20220302120108_b22-MCO-16-3-02500","doi-asserted-by":"publisher","first-page":"479","DOI":"10.6004\/jnccn.2019.0023","article-title":"Prostate cancer version 2.2019, NCCN clinical practise guidelines in oncology","volume":"17","author":"Mohler","year":"2019","journal-title":"J Natl Compr Canc Netw"},{"key":"key20220302120108_b23-MCO-16-3-02500","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1097\/00000478-199604000-00004","article-title":"1996. Prostatic carcinoma with abundant xanthomatous cytoplasm. Foamy gland carcinoma","volume":"20","author":"Nelson","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"key20220302120108_b24-MCO-16-3-02500","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1097\/00000478-199703000-00004","article-title":"Adenocarcinoma of the prostate with atrophic feature","volume":"21","author":"Cina","year":"1997","journal-title":"Am J Surg Pathol"},{"key":"key20220302120108_b25-MCO-16-3-02500","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1097\/00000478-199810000-00009","article-title":"Pseudohyperplastic prostatic adenocarcinoma","volume":"22","author":"Humphrey","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"key20220302120108_b26-MCO-16-3-02500","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1097\/00000478-200008000-00001","article-title":"Pseudohyperplastic prostatic adenocarcinoma in needle biopsy and simple prostatectomy","volume":"24","author":"Wolf","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"key20220302120108_b27-MCO-16-3-02500","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/PAS.0b013e3181d2a549","article-title":"Microcystic adenocarcinoma of the prostate: A variant of pseudohyperplastic and atrophic patterns","volume":"34","author":"Yaskiv","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"key20220302120108_b28-MCO-16-3-02500","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1097\/00000478-200008000-00001","article-title":"Pseudohyperplastic prostatic adenocarcinoma in needle biopsy and simple prostatectomy","volume":"24","author":"Levi","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"key20220302120108_b29-MCO-16-3-02500","doi-asserted-by":"publisher","first-page":"683","DOI":"10.5858\/2005-129-0683-PGCCOT","article-title":"Pleomorphic giant cell carcinoma of the prostate","volume":"129","author":"Lopez-Beltran","year":"2005","journal-title":"Arch Pathol Lab Med"},{"key":"key20220302120108_b30-MCO-16-3-02500","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1097\/01.pas.0000209841.77595.4b","article-title":"Pleomorphic giant cell adenocarcinoma of the prostate: Report of 6 cases","volume":"30","author":"Parwani","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"key20220302120108_b31-MCO-16-3-02500","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1097\/01.pas.0000209838.92842.bf","article-title":"Sarcomatoid carcinoma of the prostate: A study of 42 cases","volume":"30","author":"Hansel","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"key20220302120108_b32-MCO-16-3-02500","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1097\/PAS.0000000000000820","article-title":"Contemporary gleason grading of prostatic carcinoma: An update with discussion of practical issues to implement the 2014 international society of urological pathology (ISUP) consensus conference on gleason grading of prostatic carcinoma","volume":"41","author":"Epstein","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"key20220302120108_b33-MCO-16-3-02500","doi-asserted-by":"publisher","first-page":"S64","DOI":"10.1038\/modpathol.2017.137","article-title":"Variants of acinar adenocarcinoma of the prostate mimicking benign conditions","volume":"31 (S1)","author":"Humphrey","year":"2018","journal-title":"Mod Pathol"},{"key":"key20220302120108_b34-MCO-16-3-02500","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1097\/PAS.0b013e3182495dee","article-title":"Usual and unusual histologic patterns of high Gleason score 8 to 10 adenocarcinoma of the prostate in needle biopsy tissue","volume":"36","author":"Gottipati","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"key20220302120108_b35-MCO-16-3-02500","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","article-title":"The 2014 international society of urological pathology (ISUP) consensus conference on gleason grading of prostatic carcinoma: Definition of grading patterns and proposal for a new grading system","volume":"40","author":"Epstein","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"key20220302120108_b36-MCO-16-3-02500","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/ng.3503","article-title":"Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer","volume":"48","author":"Al-Ahmadie","year":"2016","journal-title":"Nat Genet"},{"key":"key20220302120108_b37-MCO-16-3-02500","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10689-007-9172-6","article-title":"Hereditary diffuse gastric cancer: Association with lobular breast cancer","volume":"7","author":"Schrader","year":"2008","journal-title":"Fam Cancer"},{"key":"key20220302120108_b38-MCO-16-3-02500","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1093\/hmg\/ddp046","article-title":"Germline CDH1 deletions in hereditary diffuse gastric cancer families","volume":"18","author":"Oliveira","year":"2009","journal-title":"Hum Mol Genet"},{"key":"key20220302120108_b39-MCO-16-3-02500","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S0002-9440(10)65129-2","article-title":"Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation","volume":"155","author":"Keller","year":"1999","journal-title":"Am J Pathol"},{"key":"key20220302120108_b40-MCO-16-3-02500","first-page":"277","article-title":"Plasmacytoid transitional cell carcinoma. Report of a case with initial presentation mimicking multiple myeloma","volume":"35","author":"Sahin","year":"1991","journal-title":"Acta Cytol"},{"key":"key20220302120108_b41-MCO-16-3-02500","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/j.1365-2559.2005.02153.x","article-title":"Urothelial neoplasia with plasmacytoid morphology","volume":"48","author":"Coyne","year":"2006","journal-title":"Histopathology"},{"key":"key20220302120108_b42-MCO-16-3-02500","doi-asserted-by":"publisher","first-page":"381","DOI":"10.4103\/0974-7796.184897","article-title":"Plasmacytoid urothelial carcinoma of the bladder with extensive scrotal wall invasion","volume":"8","author":"Wang","year":"2016","journal-title":"Urol Ann"},{"key":"key20220302120108_b43-MCO-16-3-02500","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.1016\/j.juro.2008.07.035","article-title":"Plasmacytoid urothelial carcinoma of the bladder: Histological and clinical features of 5 cases","volume":"180","author":"Fritsche","year":"2008","journal-title":"J Urol"},{"key":"key20220302120108_b44-MCO-16-3-02500","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.canlet.2012.12.012","article-title":"Trefoil factor 1 suppression of E-CADHERIN enhances prostate carcinoma cell invasiveness and metastasis","volume":"332","author":"Bougen","year":"2013","journal-title":"Cancer Lett"},{"key":"key20220302120108_b45-MCO-16-3-02500","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/nrurol.2011.85","article-title":"Epithelial-to-mesenchymal transition in prostate cancer: Paradigm or puzzle?","volume":"8","author":"Nauseef","year":"2011","journal-title":"Nat Rev Urol"},{"key":"key20220302120108_b46-MCO-16-3-02500","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.mce.2016.12.026","article-title":"Diverse pathways of epithelial mesenchymal transition related with cancer progression and metastasis and potential effects of endocrine disrupting chemicals on epithelial mesenchymal transition process","volume":"457","author":"Lee","year":"2017","journal-title":"Mol Cell Endocrinol"},{"key":"key20220302120108_b47-MCO-16-3-02500","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1002\/jcb.20032","article-title":"Dual roles of E-cadherin in prostate cancer invasion","volume":"91","author":"Chunthapong","year":"2004","journal-title":"J Cell Biochem"},{"issue":"137","key":"key20220302120108_b48-MCO-16-3-02500","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0000000000000563","article-title":"Prostate cancer grading: A contemporary photomontage","volume":"40","author":"Epstein","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"key20220302120108_b49-MCO-16-3-02500","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1097\/PAS.0000000000000238","article-title":"Best practices recommendations in the application of immunohistochemistry in the prostate: Report from the international society of urologic pathology consensus conference","volume":"38","author":"Epstein","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"key20220302120108_b50-MCO-16-3-02500","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/jcb.20794","article-title":"Molecular regulation of androgen action in prostate cancer","volume":"99","author":"Dehm","year":"2006","journal-title":"J Cell Biochem"},{"issue":"e19707","key":"key20220302120108_b51-MCO-16-3-02500","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000019707","article-title":"Prognostic significance of E-cadherin expression in prostatic carcinoma: A protocol for systematic review and meta-analysis","volume":"99","author":"Zhang","year":"2020","journal-title":"Medicine (Baltimore)"}],"container-title":["Molecular and Clinical Oncology"],"original-title":[],"deposited":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T10:01:16Z","timestamp":1646215276000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/mco.2022.2500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,20]]},"references-count":51,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,1,20]]}},"URL":"https:\/\/doi.org\/10.3892\/mco.2022.2500","relation":{},"ISSN":["2049-9450","2049-9469"],"issn-type":[{"value":"2049-9450","type":"print"},{"value":"2049-9469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,20]]},"article-number":"67"}}